Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study). (Q43951950)
scientific article
Language:
(P31) (Q13442814)
(P304) 245-255
(P407) (Q1860)
(P433) 4
(P478) 105
(P577) Monday, April 1, 2002
(P921) (Q183)
(Q269829)
(Q11085)
(Q300989)
(Q40)
(P1433) (Q4676732)
(P1476) "Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)." (language: en)
(P2093) W H Poewe
G Deuschl
A Gordin
E-R Kultalahti
M Leinonen
Celomen Study Group
(P2860) (Q39419773)
(Q40981288)
(Q38629056)
(Q40579561)
(Q48125712)
(Q41351656)
(Q33648357)
(Q54002951)
(Q35456745)
(Q34070854)
(Q43709671)
(Q36317207)
(Q42547557)
(Q64786892)
(Q69626259)
(Q48438194)
(Q67234347)
(Q64867890)
(Q64909913)
(Q64955113)
other details
description scientific article

External Links